HR 1392 · 111th Congress · Health

To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.

Introduced 2009-03-09· Sponsored by Rep. Green, Gene [D-TX-29]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2009-03-10)

Plain Language Summary

[AI summary unavailable — showing source text] Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance). Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

9 Democrats11 Republicans